Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Japan · Delayed Price · Currency is JPY

2,435.00

-30.00 (-1.22%)

Jul 10, 2026, 3:20 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Others	3.69B	3.45B	2.83B	2.38B	1.96B
Others Growth	6.90%	21.94%	18.86%	21.23%	9.54%
Unallocated Adjustment	-12.32B	-11.44B	-9.36B	-8.95B	-7.57B
Americas	23.16B	22.59B	20.07B	18.08B	11.19B
Americas Growth	2.49%	12.55%	11.05%	61.58%	27.44%
Japan	174.00B	168.85B	160.17B	140.51B	124.80B
Japan Growth	3.05%	5.42%	13.99%	12.59%	4.89%
Europe	24.09B	19.33B	14.02B	12.25B	10.34B
Europe Growth	24.61%	37.95%	14.44%	18.40%	26.12%
Asia	131.11B	105.84B	83.11B	74.40B	58.92B
Asia Growth	23.88%	27.35%	11.71%	26.28%	15.08%
Total	343.72B	308.62B	270.84B	238.66B	199.65B
Total Growth	11.37%	13.95%	13.48%	19.54%	10.13%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan	168.42B	163.65B	155.88B	134.78B	119.05B
Japan Growth	2.91%	4.98%	15.66%	13.21%	3.88%
Others	124.30B	99.10B	74.75B	66.19B	47.85B
Others Growth	25.42%	32.58%	12.93%	38.32%	18.58%
China	51.01B	45.87B	40.21B	37.70B	32.75B
China Growth	11.20%	14.09%	6.66%	15.12%	24.34%
Total	343.72B	308.62B	270.84B	238.66B	199.65B
Total Growth	11.37%	13.95%	13.48%	19.54%	10.13%